Latest period
1.18B
YoY change
-1.9%
5Y CAGR
+14.3%
Peak year (2022)
1.22B
Latest annual
1.17B
Shares Outstanding history chart for Viatris (VTRS) from 2003 to 2025
Latest: 1.17B
Shares Outstanding growth chart for Viatris (VTRS) from 2003 to 2025
Latest: -1.9%
Shares Outstanding history table for Viatris (VTRS) from 2003 to 2025
| 2025 | 1.17B | -1.9% | -22.60M | ||
| 2024 | 1.19B | -1.1% | -13.60M | ||
| 2023 | 1.21B | -0.9% | -10.50M | ||
| 2022 | 1.22B | +0.7% | +8.60M | ||
| 2021 | 1.21B | +101.1% | +607.60M | ||
| 2020 | 601.20M | +16.4% | +84.70M | ||
| 2019 | 516.50M | 0.0% | 0 | ||
| 2018 | 516.50M | -3.8% | -20.20M | ||
| 2017 | 536.70M | +3.1% | +16.20M | ||
| 2016 | 520.50M | +4.6% | +23.10M | ||
| 2015 | 497.40M | +25.0% | +99.40M | ||
| 2014 | 398.00M | +0.9% | +3.50M | ||
| 2013 | 394.50M | -6.1% | -25.74M | ||
| 2012 | 420.24M | -4.2% | -18.55M | ||
| 2011 | 438.79M | +33.4% | +109.81M | ||
| 2010 | 328.98M | +7.2% | +22.07M | ||
| 2009 | 306.91M | +0.8% | +2.55M | ||
| 2008 | 304.36M | +18.4% | +47.21M | ||
| 2007 | 257.15M | — | — | ||
| 2005 | 234.21M | -14.4% | -39.41M | ||
| 2004 | 273.62M | -1.0% | -2.70M | ||
| 2003 | 276.32M | — | — |
- 20251.17B-1.9%
- 20241.19B-1.1%
- 20231.21B-0.9%
- 20221.22B+0.7%
- 20211.21B+101.1%
- 2020601.20M+16.4%
- 2019516.50M0.0%
- 2018516.50M-3.8%
- 2017536.70M+3.1%
- 2016520.50M+4.6%
- 2015497.40M+25.0%
- 2014398.00M+0.9%
- 2013394.50M-6.1%
- 2012420.24M-4.2%
- 2011438.79M+33.4%
- 2010328.98M+7.2%
- 2009306.91M+0.8%
- 2008304.36M+18.4%
- 2007257.15M—
- 2005234.21M-14.4%
- 2004273.62M-1.0%
- 2003276.32M—
Shares Outstanding values are taken from Viatris's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.18B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Viatris (VTRS) diluted shares outstanding is 1.17B – edged down 1.9% year-over-year.
Through 2020–2025 (5 years), Viatris diluted shares outstanding delivered a +14.3% annualised rate; with mixed annual results across the window.
Viatris diluted shares outstanding peaked at 1.22B in 2022; the latest annual figure is 1.17B in 2025 (3.8% below peak).
Across the available history, diluted shares outstanding reached its high of 1.22B in 2022 and its low of 234.21M in 2005.
Viatris Shares Outstanding by Year
Viatris Shares Outstanding 2025: 1.17B
Viatris diluted shares outstanding in 2025 was 1.17B, edged down 1.9% below 2024.
Viatris Shares Outstanding 2024: 1.19B
2024's diluted shares outstanding for Viatris came in at 1.19B, edged down 1.1% below 2023.
Viatris Shares Outstanding 2023: 1.21B
Viatris posted diluted shares outstanding of 1.21B in 2023, edged down 0.9% below 2022.
Viatris Shares Outstanding 2022: 1.22B
In 2022, Viatris reported diluted shares outstanding of 1.22B, edged up 0.7% from 2021. This figure represents the highest annual value in the available history.
Viatris Shares Outstanding 2021: 1.21B
Viatris diluted shares outstanding in 2021 was 1.21B.
See more financial history for Viatris (VTRS).
Sector peers by Shares Outstanding
Healthcare peers of Viatris (VTRS), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation